These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 17000218

  • 1. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR, Restrepo MI, Mortensen EM, Burgess DS.
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [Abstract] [Full Text] [Related]

  • 2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [Abstract] [Full Text] [Related]

  • 3. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN.
    Arch Intern Med; 2009 Sep 14; 169(16):1525-31. PubMed ID: 19752411
    [Abstract] [Full Text] [Related]

  • 4. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
    Mortensen EM, Restrepo M, Anzueto A, Pugh J.
    Am J Med; 2004 Nov 15; 117(10):726-31. PubMed ID: 15541321
    [Abstract] [Full Text] [Related]

  • 5. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA, Community-Acquired Pneumonia Organization (CAPO) Investigators.
    Arch Intern Med; 2009 Sep 14; 169(16):1515-24. PubMed ID: 19752410
    [Abstract] [Full Text] [Related]

  • 6. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia.
    El Solh AA, Akinnusi ME, Alfarah Z, Patel A.
    J Am Geriatr Soc; 2009 Jun 14; 57(6):1030-5. PubMed ID: 19460091
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic therapy and 48-hour mortality for patients with pneumonia.
    Mortensen EM, Restrepo MI, Anzueto A, Pugh JA.
    Am J Med; 2006 Oct 14; 119(10):859-64. PubMed ID: 17000217
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB, Rhew DC, Wong JY, Charles RA, Goetz MB, American Thoracic Society.
    Arch Intern Med; 2003 Jul 28; 163(14):1718-26. PubMed ID: 12885688
    [Abstract] [Full Text] [Related]

  • 9. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
    Lancaster JW, Lawrence KR, Fong JJ, Doron SI, Garpestad E, Nasraway SA, Devlin JW.
    Pharmacotherapy; 2008 Jul 28; 28(7):852-62. PubMed ID: 18576900
    [Abstract] [Full Text] [Related]

  • 10. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.
    Wu JH, Howard DH, McGowan JE, Turpin RS, Henry Hu X.
    Clin Ther; 2006 Sep 28; 28(9):1451-61. PubMed ID: 17062317
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic therapy of hospitalized patients with community-acquired pneumonia: an international perspective from the CAPO Cohort Study.
    Peyrani P, Christensen D, LaJoie AS, Nakamatsu R, Arnold F, Schulz P, Toala I, Ramirez A, Lobo S, Johnson B, Chesnut D, Richmond B, De La Cruz R, Carrico R, Ramirez J, Community-Acquired Pneumonia Organization Investigators.
    J Ky Med Assoc; 2006 Nov 28; 104(11):513-7. PubMed ID: 17175853
    [Abstract] [Full Text] [Related]

  • 12. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S, Martínez Tomas R, Cremades Romero MJ, Martínez Moragón E, Soler Cataluña JJ, Menéndez Villanueva R.
    Respir Med; 2007 Sep 28; 101(9):1909-15. PubMed ID: 17628462
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK, Nopmaneejumruslers C, Chan CK.
    Am J Med; 2004 Mar 15; 116(6):385-93. PubMed ID: 15006587
    [Abstract] [Full Text] [Related]

  • 14. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.
    Arch Intern Med; 2004 Mar 22; 164(6):637-44. PubMed ID: 15037492
    [Abstract] [Full Text] [Related]

  • 15. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A, Kuzmanic G, Platzer L, Sanfuentes F, Espinoza MA, Saldías F.
    Rev Med Chil; 2003 Aug 22; 131(8):847-56. PubMed ID: 14558238
    [Abstract] [Full Text] [Related]

  • 16. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW, Lindstrom ST.
    Respirology; 2007 Sep 22; 12(5):754-8. PubMed ID: 17875067
    [Abstract] [Full Text] [Related]

  • 17. Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.
    Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR.
    Respir Med; 2012 Nov 22; 106(11):1606-12. PubMed ID: 22917808
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI, Slater LN, Kurdgelashvili G, Husain KO, Gentry CA.
    Ann Pharmacother; 2013 Jan 22; 47(1):9-19. PubMed ID: 23324506
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia.
    Chalmers JD, Singanayagam A, Akram AR, Choudhury G, Mandal P, Hill AT.
    J Antimicrob Chemother; 2011 Feb 22; 66(2):416-23. PubMed ID: 21081545
    [Abstract] [Full Text] [Related]

  • 20. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.
    Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, Bilbao A.
    Clin Infect Dis; 2004 Oct 01; 39(7):955-63. PubMed ID: 15472846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.